You are viewing AANS Neurosurgeon Volume 27, Number 4, 2018. View our current issue, Volume 28, Number 3, 2019

AANS Neurosurgeon | Volume 27, Number 4, 2018

Advertisement

New Drug Combination Shows Promise for Common Pediatric Brain Tumor

Print Friendly, PDF & Email

A new combination treatment aimed at resistant and recurrent low-grade gliomas slowed tumor growth and killed tumor cells in laboratory and mouse models.

Researchers at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine combined carboplatin, a standard chemotherapy drug that works well against these brain tumors, and everolimus, which blocks an enzyme called mTOR that was shown in earlier research to fuel the growth of these tumors. The combination increased DNA damage and cell death in laboratory models.

Pediatric low-grade glioma is the most common brain tumor in children and can often be treated with surgery alone. However, some patients have tumors in locations that make surgery too risky, such as near optic nerves or in the mid-brain area, or have their tumors grow back after surgery.

Read More

Calendar/Courses

No upcoming events

Comments are closed.